Drug
1 alpha-hydroxyergocalciferol clinical trials
Also written doxercalciferol and Hectorol®.
How studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 4 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 11
Genzyme, a Sanofi Company (5) · University of Wisconsin, Madison (3) · Creighton University (1) · Mariana Markell (1) · Indiana University School of Medicine (1) · Duke University (1) · Indiana University (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
Often tested with
Tested in the same studies.
Paricalcitol (3) · Cholecalciferol (1) · Calcitriol (1) · Sevelamer (1) · Calcium Carbonate (1) · Docetaxel (1)
Studies
Open first, then newest update. How each study uses 1 alpha-hydroxyergocalciferol is read from its arms, and is right about nine times in ten.
Testing it · 18
- Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on DialysisTerminatedPhase 3SanofiNCT02859896Written as Doxercalciferol (GZ427397)
- To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year StudyCompletedPhase 2/3Creighton UniversityNCT07660536Written as doxercalciferol capsules, Hectorol®
- Doxercalciferol Before Surgery in Treating Localized Prostate CancerCompletedPhase 2University of Wisconsin, MadisonNCT00022412Written as doxercalciferol
- Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate CancerTerminatedPhase 2University of Wisconsin, MadisonNCT00582582Written as Docetaxel plus doxercalciferol
- Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaCompletedPhase 2University of Wisconsin, MadisonNCT00052832Written as doxercalciferol
- Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant RecipientsCompletedPhase 4Mariana MarkellNCT00889629Written as Doxercalciferol
- Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney DiseaseCompletedNot applicableIndiana University School of MedicineNCT00285467Written as doxercalciferol
- How Vitamin D Analogues Affect Endothelial Cells in Patients on DialysisCompletedPhase 4Duke UniversityNCT00528788Written as doxercalciferol
- A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on HemodialysisCompletedPhase 4Genzyme, a Sanofi CompanyNCT00454350Written as Hectorol (doxercalciferol injection)
- A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® InjectionCompletedPhase 4Genzyme, a Sanofi CompanyNCT00463021Written as Hectorol (doxercalciferol capsules)
- Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary HyperparathyroidismCompletedPhase 4Genzyme, a Sanofi CompanyNCT00123461Written as Hectorol (doxercalciferol capsules), 0.5mcg
- A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on DialysisCompletedPhase 4Genzyme, a Sanofi CompanyNCT00418600Written as Hectorol® (doxercalciferol capsules)
- Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant PatientsTerminatedPhase 4Emory UniversityNCT00646282Written as doxercalciferol
- A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe PsoriasisCompletedPhase 2Genzyme, a Sanofi CompanyNCT00601107Written as Doxercalciferol
- The Role of Vitamin D in Immune Function in Patients With Chronic Kidney Disease (CKD) Stages 3 and 4.CompletedPhase 4Indiana UniversityNCT00749736Written as doxercalciferol
- Doxercalciferol in Recurrent Pediatric Solid TumorsTerminatedPhase 1M.D. Anderson Cancer CenterNCT00511017Written as Doxercalciferol
- Regulation of Bone Formation in Renal OsteodystrophyCompletedPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00560300Written as 1 alpha D2
- A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney DiseaseCompletedPhase 4AbbottNCT00257920Written as Hectorol® injection
Given in every arm · 1 — 1 alpha-hydroxyergocalciferol is usual care beside what is tested
As the comparator · 1 — what is tested is compared with 1 alpha-hydroxyergocalciferol
Codes
What other systems call 1 alpha-hydroxyergocalciferol · ClinicalTrials.gg INT003161
- MeSH (NLM) C0425331 alpha-hydroxyergocalciferolConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3DIZ9LF5Y9DOXERCALCIFEROLConfirmed FDA, NLM
- RxNorm 11516One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C042533 | 1 alpha-hydroxyergocalciferol | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3DIZ9LF5Y9 | DOXERCALCIFEROL | Confirmed FDA, NLM |
| RxNorm | 11516 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.